485 related articles for article (PubMed ID: 33283990)
21. Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies.
Daniel-Moreno A; Lamsfus-Calle A; Wilber A; Chambers CB; Johnston I; Antony JS; Epting T; Handgretinger R; Mezger M
Blood Cells Mol Dis; 2020 Sep; 84():102456. PubMed ID: 32498026
[TBL] [Abstract][Full Text] [Related]
22. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
[TBL] [Abstract][Full Text] [Related]
23. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
Allard P; Alhaj N; Lobitz S; Cario H; Jarisch A; Grosse R; Oevermann L; Hakimeh D; Tagliaferri L; Kohne E; Kopp-Schneider A; Kulozik AE; Kunz JB
Haematologica; 2022 Jul; 107(7):1577-1588. PubMed ID: 34706496
[TBL] [Abstract][Full Text] [Related]
24. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
25. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
[TBL] [Abstract][Full Text] [Related]
26. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.
Cardoso GL; Diniz IG; Silva AN; Cunha DA; Silva Junior JS; Uchôa CT; Santos SE; Trindade SM; Cardoso Mdo S; Guerreiro JF
Blood Cells Mol Dis; 2014 Dec; 53(4):176-9. PubMed ID: 25084696
[TBL] [Abstract][Full Text] [Related]
27. Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences.
Finotti A; Gasparello J; Zuccato C; Cosenza LC; Fabbri E; Bianchi N; Gambari R
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895276
[TBL] [Abstract][Full Text] [Related]
28. Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy.
Brendel C; Negre O; Rothe M; Guda S; Parsons G; Harris C; McGuinness M; Abriss D; Tsytsykova A; Klatt D; Bentler M; Pellin D; Christiansen L; Schambach A; Manis J; Trebeden-Negre H; Bonner M; Esrick E; Veres G; Armant M; Williams DA
Mol Ther Methods Clin Dev; 2020 Jun; 17():589-600. PubMed ID: 32300607
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
[TBL] [Abstract][Full Text] [Related]
30. The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34
Drakopoulou E; Georgomanoli M; Lederer CW; Panetsos F; Kleanthous M; Voskaridou E; Valakos D; Papanikolaou E; Anagnou NP
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560719
[TBL] [Abstract][Full Text] [Related]
31. Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
Kanter J; Walters MC; Krishnamurti L; Mapara MY; Kwiatkowski JL; Rifkin-Zenenberg S; Aygun B; Kasow KA; Pierciey FJ; Bonner M; Miller A; Zhang X; Lynch J; Kim D; Ribeil JA; Asmal M; Goyal S; Thompson AA; Tisdale JF
N Engl J Med; 2022 Feb; 386(7):617-628. PubMed ID: 34898139
[TBL] [Abstract][Full Text] [Related]
32. miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction.
Guda S; Brendel C; Renella R; Du P; Bauer DE; Canver MC; Grenier JK; Grimson AW; Kamran SC; Thornton J; de Boer H; Root DE; Milsom MD; Orkin SH; Gregory RI; Williams DA
Mol Ther; 2015 Sep; 23(9):1465-74. PubMed ID: 26080908
[TBL] [Abstract][Full Text] [Related]
33. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Frangoul H; Altshuler D; Cappellini MD; Chen YS; Domm J; Eustace BK; Foell J; de la Fuente J; Grupp S; Handgretinger R; Ho TW; Kattamis A; Kernytsky A; Lekstrom-Himes J; Li AM; Locatelli F; Mapara MY; de Montalembert M; Rondelli D; Sharma A; Sheth S; Soni S; Steinberg MH; Wall D; Yen A; Corbacioglu S
N Engl J Med; 2021 Jan; 384(3):252-260. PubMed ID: 33283989
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.
Pule GD; Mowla S; Novitzky N; Wiysonge CS; Wonkam A
Expert Rev Hematol; 2015 Oct; 8(5):669-79. PubMed ID: 26327494
[TBL] [Abstract][Full Text] [Related]
36. SIRT1 activates the expression of fetal hemoglobin genes.
Dai Y; Chen T; Ijaz H; Cho EH; Steinberg MH
Am J Hematol; 2017 Nov; 92(11):1177-1186. PubMed ID: 28776729
[TBL] [Abstract][Full Text] [Related]
37. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic base editing of human hematopoietic stem cells.
Zeng J; Wu Y; Ren C; Bonanno J; Shen AH; Shea D; Gehrke JM; Clement K; Luk K; Yao Q; Kim R; Wolfe SA; Manis JP; Pinello L; Joung JK; Bauer DE
Nat Med; 2020 Apr; 26(4):535-541. PubMed ID: 32284612
[TBL] [Abstract][Full Text] [Related]
39. Potent and uniform fetal hemoglobin induction via base editing.
Mayuranathan T; Newby GA; Feng R; Yao Y; Mayberry KD; Lazzarotto CR; Li Y; Levine RM; Nimmagadda N; Dempsey E; Kang G; Porter SN; Doerfler PA; Zhang J; Jang Y; Chen J; Bell HW; Crossley M; Bhoopalan SV; Sharma A; Tisdale JF; Pruett-Miller SM; Cheng Y; Tsai SQ; Liu DR; Weiss MJ; Yen JS
Nat Genet; 2023 Jul; 55(7):1210-1220. PubMed ID: 37400614
[TBL] [Abstract][Full Text] [Related]
40. Bach1 inhibitor HPP-D mediates γ-globin gene activation in sickle erythroid progenitors.
Palani CD; Zhu X; Alagar M; Attucks OC; Pace BS
Blood Cells Mol Dis; 2024 Jan; 104():102792. PubMed ID: 37633023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
